http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2099056-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_309342117bed9eb95422c52e5786f902 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate | 1994-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1997-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55ee8ef550079f80d50b43cab4b56f79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c414baa3020b295596cc96dcd95a0c4d |
| publicationDate | 1997-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2099056-C1 |
| titleOfInvention | Method of tuberculosis treatment |
| abstract | FIELD: medicine, phthisiology. SUBSTANCE: method involves the use of complex therapy in combination with betamecil - β--form of methyluracil. Betamecil is administrated orally as tablets or powders, 3 times per a day, or by inhalation or intratracheal route as 0.6-1.2% an aqueous solution, once per a day. Single dose of betamecil is 0.03-0.06 g. EFFECT: enhanced effectiveness of treatment. |
| priorityDate | 1994-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.